This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Is Philip Morris (PM) Up 2.8% Since Last Earnings Report?
by Zacks Equity Research
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Company News For May 14, 2019
by Zacks Equity Research
Companies in the news are: TEVA, FF, PM and KRNT
Philip Morris Beats, Tightens Guidance: Staple ETFs in Focus
by Zacks Equity Research
With Philip Morris (PM) outriding Q1 estimates, we discuss the market impact on some consumer staple ETFs with high-exposure to this tobacco company.
Can RRPs Lift the Performance of Tobacco Industry Players?
by Vidya Nair
While regulatory hurdles are weighing on cigarette sales, tobacco players are finding some respite in RRPs.
The Zacks Analyst Blog Highlights: Philip Morris, American Express, Honeywell, BB&T and SunTrust Banks
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Philip Morris, American Express, Honeywell, BB&T and SunTrust Banks
Strong Earnings and Retail Sales Data
by Zacks Equity Research
Strong Earnings and Retail Sales Data
Q1 Earnings Continue to Impress, Retail Sales Hit 18-Month High,
by Swarup Gupta
Investors will welcome a massive jump in retail sales even as first-quarter results continue to roll in.
Philip Morris (PM) Q1 Earnings Top Estimates, Revenues Down
by Zacks Equity Research
Philip Morris' (PM) Q1 results benefit from pricing and improved results from the RRPs category. However, the combustible unit continues to be weak.
Will Pricing & RRPs Aid Altria's (MO) Q1 Earnings Growth?
by Zacks Equity Research
Altria's (MO) Q1 performance is likely to gain from RRPs and high pricing. However, receding cigarette sales are a concern.
Philip Morris (PM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Philip Morris (PM) closed at $85.77, marking a +0.3% move from the previous day.
Will RRPs & Pricing Drive Philip Morris' (PM) Q1 Earnings?
by Zacks Equity Research
Philip Morris' (PM) Q1 performance to gain from high pricing and advancements in RRPs. However, declining cigarette volumes are a worry.
Philip Morris (PM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Philip Morris (PM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors Likely to Decide PepsiCo's (PEP) Fate in Q1 Earnings
by Zacks Equity Research
PepsiCo (PEP) displays strength on the back of robust performance at the international and snacking businesses. However, headwinds linked to the CSD category and adverse currency cannot be ignored.
Altria to Boost Interests in JUUL, Aims to Gain Voting Rights
by Zacks Equity Research
Altria (MO) provides information related to investment in JUUL to the FTC. It seeks to gain voting interests in JUUL.
Philip Morris' (PM) Year of Unsmoke Underscores Focus on RRPs
by Zacks Equity Research
Philip Morris (PM) is benefiting from focus on reduced-risk products, which is reconfirmed by its latest launch of "The Year of Unsmoke."
Is Philip Morris International (PM) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (PM) Outperforming Other Consumer Staples Stocks This Year?
Top Ranked Growth Stocks to Buy for April 4th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 4th
Why Philip Morris (PM) Could Beat Earnings Estimates Again
by Zacks Equity Research
Philip Morris (PM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights: Phillip Morris, Bristol-Myers, Walgreens, Sirius and Total System
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Phillip Morris, Bristol-Myers, Walgreens, Sirius and Total System
Philip Morris (PM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Philip Morris (PM) closed the most recent trading day at $88.39, moving +1.27% from the previous trading session.
Top Research Reports for Phillip Morris, Bristol-Myers & Walgreens Boots
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Phillip Morris (PM), Bristol-Myers (BMY) and Walgreens Boots (WBA).
Factors Likely to Influence Signet's (SIG) Earnings in Q4
by Zacks Equity Research
In spite of taking a slew of measures, Signet (SIG) posted weaker-than-expected sales figures for the holiday season, which coincides with the fourth quarter.
Factors Likely to Shape Constellation Brands (STZ) Q4 Earnings
by Zacks Equity Research
Constellation Brands (STZ) gains from constant brand-building efforts, acquisitions and e-commerce initiatives. However, a soft outlook for fiscal 2019 and higher costs are concerning.
Philip Morris Looks Alluring on Gains from RRPs & Pricing
by Zacks Equity Research
Philip Morris (PM) is progressing well with bolstering presence in the low-risk tobacco space. Further, the company's pricing strategies are yielding results.
The Zacks Analyst Blog Highlights: Deutsche Telekom, Fortescue, General Mills, Philip Morris and Southern
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Deutsche Telekom, Fortescue, General Mills, Philip Morris and Southern